Combination of gestagen and insulin sensitizer for treating PCOS
US8097604B2 · kind B2 · utility
0Cited by
0References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 1, 2008 |
| Grant date | Jan 17, 2012 |
| Priority date | — |
| Expiry date | Dec 1, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a medicament which contains as the active ingredient combination at least one gestagen with a contraceptive action as the sole hormone component and at least one insulin sensitizer, which medicament is in particular suitable for preventing or treating pathological disorders which are caused by polycystic ovary syndrome (PCOS).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.